Mona Al Mukaddam, M.D., M.S.

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine
Contact information
3rd floor Penn Medicine University City
3737 Market Street
Philadelphia, PA 19104
Office: 215-662-9905
Email: mona.almukaddam@pennmedicine.upenn.edu
Links
Report on a patient with a rare bone disease correctly diagnosed at the Penn Bone Center
Penn bone Center featured in Penn Medicine Women's health newsletter
Penn Bone Center
International Fibrodysplasia Ossificans Progressiva Association
Commentary regarding type 1 diabetes and bone in medpage today
Official website for International Clinical Council on Fibrodysplasia Ossificans Progressiva
Education:
BS
American University of Beirut, Lebanon, 2001.
 MD
American University of Beirut, Lebanon, 2005.
 MS
University of Pennsylvania, Institute of Translational Medicine and Therapeutics, 2013.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Metabolic bone and calcium disorders including osteoporosis, Paget's disease, hypo- and hyper-parathyroidism as well as bone diseases related to transplant, medications (example aromatase inhibitors and glucocorticoids) and iron overload.
Rare bone disease including Fibrodysplasia Ossificans Progressiva and hypophosphatasia.

Description of Research Expertise

Clinical research in Fibrodysplasia Ossificans Progressiva.
Evaluation of osteoporosis and the effects of treatment/diseases on "bone quality" using high resolution imaging of bone (uMRI).

Selected Publications

Christie G Turin, Robert Wilson, Ciera Mangone, Karen Rosenspire, Jessica Berman1, Michelle Walker1, Ravi Amaravadi, Mona Al Mukaddam: A Case of Tumor-Induced Osteomalacia: Finding the Culprit Acetabular Tumor and Successful Resection with a Novel Hip Joint-Preserving Surgery. Journal of Orthopedic Case Reports March 2021.

 Kathryn McCrystal Dahir, Jennifer Mcginniss, Scott Mellis, Robert J. Sanchez, Maja Di Rocco, Richard Keen, Philippe Orcel, Thomas Funck-Brentano, Christian Roux, Sami Kolta,Annalisa Madeo, Judith S. Bubbear, Jacek Tabarkiewicz,Małgorzata Szczepanek, Javier Bachiller-Corral, Angela M. Cheung, Esmée Botman, Mona Al Mukaddam, Lianne Tile, Cynthia Portal-Celhay, Neena Sarkar, Peijie Hou, Eduardo Forleo-Neto, Andrew J. Rankin, Aris N. Economides, Dinko Gonzalez Trotter, E. Marelise W. Eekhoff, Frederick S. Kaplan, Robert J. Pignolo: Garetosmab Reduces Flare-ups in Patients With Fibrodysplasia Ossificans Progressiva. Oral presentation at Endocrine virtual meeting 2021 March 2021.

 Christopher Hvisdas, Kruti Patel, Anisa Sulaj, Richie Tran, Mona Al Mukaddam: Experience With Anti-Sclerostin Antibody for Osteoporosis Patient With End-Stage Renal Disease on Hemodialysis. ePoster for Endocrine virtual meeting 2021 March 2021.

 Rajapakse CS, Johncola AJ, Batzdorf AS, Jones BC, Al Mukaddam M, Sexton K, Shults J, Leonard MB, Snyder PJ, Wehrli FW.: Effect of Low Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomized Placebo-Controlled Trial. Journal of Bone Mineral Research Dec 2020.

 Frederick S.Kaplan, Mona Al Mukaddam, Alexandra Stanley, O.Will Towler, Eileen M.Shore: Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. Bone 140, November 2020.

 Robert J. Pignolo, Geneviève Baujat, Matthew A. Brown, Carmen De Cunto, Maja Di Rocco, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Andrew Strahs, Donna R. Grogan, Rose Marino, Frederick S. Kaplan: Measuring Outcomes in Ultra-Rare Bone Diseases: Methodology of the Palovarotene Fibrodysplasia Ossificans Progressiva Clinical Development Program. eposter for ASBMR annual meeting Sept 2020.

 Robert J. Pignolo, Mona Al Mukaddam, Geneviève Baujat, Staffan K. Berglund, Angela M. Cheung, Carmen De Cunto, Patricia Delai, Maja Di Rocco, Nobuhiko Haga, Edward C. Hsiao, Peter Kannu, Richard Keen, Edna E. Mancilla, Donna R. Grogan, Rose Marino, Andrew Strahs, Frederick S. Kaplan : Palovarotene (PVO) for fibrodysplasia ossificans progressiva (FOP): Data from the phase III MOVE trial oral presentation at ASBMR annual meeting Sept 2020.

 Robert J. Pignolo, Mona Al Mukaddam, Geneviève Baujat, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Kathleen Harnett, Rose Marino, Frederick S. Kaplan: Longitudinal and flare-up-specific biomarkers in fibrodysplasia ossificans progressiva (FOP): Data from a global natural history study. eposter for ASBMR annual meeting Sept 2020.

 Edward C. Hsiao, Mona Al Mukaddam, Geneviève Baujat, Carmen De Cunto, Richard Keen, Robert J. Pignolo, Kathleen Harnett, Rose Marino, Frederick S. Kaplan: Use of assistive devices and adaptations by individuals with fibrodysplasia ossificans progressiva (FOP): Data from a global natural history study. eposter for ASBMR annual meeting Sept 2020.

 Maja Di Rocco, Eduardo Forleo-Neto, Robert Pignolo, Richard Keen, Philippe Orcel, Thomas Funck-Brentano, Christian Roux, Sami Kolta, Annalisa Madeo, Judith S Bubbear, Jacek Tabarkiewicz, Małgorzata Szczepanek, Javier Bachiller-Corral, Angela M Cheung, Kathryn M Dahir, Esmée Botman, Pieter G Raijmakers, Mona Al Mukaddam, Lianne Tile, Cynthia Portal-Celhay, Melissa Simek-Lemos, Bret Musser, Neena Sarkar, Peijie Hou, Anita Boyapati, Su Liang, Marcella Ruddy, Scott Mellis, Andrew J. Rankin, Aris N. Economides, Dinko Gonzalez Trotter, Gary Herman, David M. Weinreich, George D. Yancopoulos, E. Marelise W. Eekhoff, and Frederick S. Kaplan, on behalf of the LUMINA-1 Investigators : Garetosmab, an Inhibitor of Activin-A, Reduces Formation of Heterotopic Bone and Soft Tissue Flare-Ups in Patients with Fibrodysplasia Ossificans Progressiva. oral presentation at ASBMR annual meeting Sept 2020.
back to top
Last updated: 01/21/2021
The Trustees of the University of Pennsylvania
 
Back to Top